Table 2.
Antibiotic | Experimental Model |
Bacteria Decreased | Bacteria Increased | Time for Gut to Recover | Long Term Impacts |
---|---|---|---|---|---|
Doxycycline [57] | Human | Enterobacteriaceae, Enterococcus spp., Escherichia coli, Streptococcus spp., and Fusobacterium spp. | Not Applicable | 9 days after treatment | Not Applicable |
Doxycycline [59] | Human | Bifidobacterium | Not Applicable | Not Applicable | Increase in tetracycline resistance |
Doxycycline [62] | Human | Escherichia coli, Enterococcaceae | Not Applicable | 4 weeks after 16-week treatment | Increased doxycycline resistance |
Tetracycline [60] | Honeybee |
Lactobacillus, Frischella, Commensalibacter, Bartonella, Gilliamella, Snodgrassella |
Not Applicable | Did not recover | Gut microbiota did not recover in treated bees. This could harm the colony as contact with hive mates is a major contributor to bee microbiota |
Tetracycline [61] | Honeybee |
Bifidobacterium, Firm-4, Firm-5, Snodgrassella alvi, Alpha 2.1, Frischella perrara, Lactobacillus kunkeei, Bartonella apis |
Serratia, Halomonadaceae, Gilliamella apicola |
32% of treated bees recovered 3 days after treatment | Tetracycline-treated bees have increased mortality |